This lecture was supported by Grant Number 6H79FG000999-01M001 from SAMHSA. Its contents are solely the responsibility of the authors and do not necessarily represent the official views of SAMHSA.  

About the speakers

Diana E. Clarke, PhD, is the Managing Director of Research and Senior Epidemiologist/Research Statistician at the American Psychiatric Association. She is also an Adjunct Assistant Professor in the Department of Mental Health at the Johns Hopkins Bloomberg School of Public Health. Most recently, she was elected as president-elect for the International Academy of Suicide Research (IASR).

Dr. Clarke conducts research on the assessment and prevention of mental and substance use disorders including suicide and suicidal behaviors. Also, she researches gaps in training for behavioral health providers and the potential impact on patient outcomes.

Kiara Alvarez, PhD is a Bloomberg Assistant Professor of American Health at the Johns Hopkins Bloomberg School of Public Health with a joint appointment in the School of Medicine. She is a licensed psychologist. Her research focuses on youth mental health equity, suicide prevention, and the well-being of Latinx and immigrant youth, including family-centered approaches to integrating mental health into primary care and community settings. She is on the Board of Directors for the Society for Prevention Research and steering committee for the Youth Suicide Research Consortium.

Dr. Dale Adair currently serves as the Pennsylvania Department of Human Services (DHS) Chief Psychiatric Officer and the Medical Director for the Office of Mental Health and Substance Abuse Services (OMHSAS). In this role, he provides clinical expertise and consultation to the Deputy Secretary of OMHSAS and the Secretary of DHS. He provides input and guidance into the policies that affect the provision of mental health and substance use treatment throughout the state. He has been a leader in the development of the vision for PA’s First Episode Psychosis program; PA team efforts with the Center for Medicare and Medicaid Innovation Accelerator-Substance Use Disorder project; Centers of Excellence (COE) for the treatment of Opioid Use Disorder; Health Equity; and served as Project lead for the PA Certified Community Behavioral Health Clinic Program. He is involved with numerous efforts aimed at suicide prevention and currently serves as the lead on Pennsylvania’s efforts to implement 988 as the new 3-digit number for the Suicide Prevention and Crisis Lifeline and the PA Black Youth Suicide Workgroup. He has worked on numerous projects for the Department to improve access and quality of care for Medicaid beneficiaries while containing costs. One of those projects is an Integrated Care Plan Program which requires the Physical and Behavioral Health Managed Care Organizations to work together caring for shared patients. He has served as Co-chair for the Behavioral Health Commission for Adult Mental Health. He serves on the PA Threat Assessment Steering Committee (PA-TASC), the National Committee for Quality Assurance (NCQA) Patient-Centered Outcomes Behavioral Health Expert Working Group, the NCQA Certified Community Behavioral Health Clinic (CCBHC) Advisory Panel, and the National Academy for State Health Policy (NASHP) Behavioral Health, Aging, and Disability Steering Committee. He served as a consultant for the Centers for Medicaid and Medicare Services (CMS). He also served as the Deputy Secretary for OMHSAS on two separate occasions where he was asked to manage a $5 billion budget. Most of his career has been spent addressing the mental health concerns of the most vulnerable citizens. Past awards include the Governor’s Award for Excellence in Leadership and the PA Rehabilitation & Community Providers Association Community Leadership Award. He is a Distinguished Life Fellow of the American Psychiatric Association.

Adrienne Grzenda, MD, PhD, is a clinical assistant professor of psychiatry and biobehavioral sciences at the David Geffen School of Medicine at UCLA and an inpatient attending at UCLA-Olive View Medical Center. Their research focuses on applications of data science, informatics, and artificial intelligence (machine learning, natural language processing) to improve the detection and prediction of mental illnesses and associated outcomes. They received an MD and PhD in biochemistry and molecular biology from an NIH-designated Medical Scientist Training Program at Mayo Clinic as well as an MS in bioinformatics and computational biology from the University of Minnesota. They completed psychiatry residency at UCLA/Semel Institute (research track), where they additionally served as program chief resident. Dr. Grzenda has received research funding from the National Institutes of Health, American Psychiatric Association Foundation, and American Foundation for Suicide Prevention, as well as fellowship awards from the Corella & Bertram F. Bonner Foundation and American College of Psychiatry. They are currently a statistical editor for the American Journal of Psychiatry.

Dr. Victoria O’Keefe is a citizen of the Cherokee Nation and a member of the Seminole Nation of Oklahoma. Dr. O’Keefe is the Santosham Endowed Chair in Native American Health at Johns Hopkins University, an Associate Professor at the Johns Hopkins Bloomberg School of Public Health, an Associate Director at the Johns Hopkins Center for Indigenous Health, and a Licensed Clinical Psychologist. Her community-based participatory research with Indigenous communities focuses on cultural strengths- suicide prevention, mental health promotion, and wellness. Dr. O’Keefe received her PhD in clinical psychology from Oklahoma State University. Dr. O’Keefe was honored by her Tribal Nation with a Cherokee Nation Community Leadership Individual Award in 2020.

Disclosure Statements

Sheppard Pratt holds the standard that its continuing medical education programs should be free of commercial bias and conflict of interest. In accord with Sheppard Pratt's Disclosure Policy, as well as standards of the Accreditation Council for Continuing Medical Education (ACCME) and the American Medical Association (AMA), all planners, reviewers, speakers and persons in control of content have been asked to disclose any relationship he /she has with any entity producing, marketing, selling, re-selling, or distributing health care goods or services consumed by, or used on, patients, during the past 24 months. All planners, reviewers and speakers have also been asked to disclose any payments accepted for this lecture from any entity besides Sheppard Pratt, and if there will be discussion of any products, services or off-label uses of product(s) during this presentation.

Diana Clarke, PhD; Dale K. Adair, MD; Kiara Alvarez, PhD; Adrienne Grzenda, MD, PhD, report that they have no relationships with any entity producing, marketing, selling, re-selling, or distributing health care goods or services consumed by, or used on, patients, during the past 24 months. They will not discuss any products, services, or off-label uses in this presentation. All relationships have been mitigated through review.

Victoria O'Keefe, PHD, MS, reports she has been a speaker and received honoraria for Jasper Health, Portland DBT Institute, and Lyra Health in the past 24 months. She will not discuss any products, services, or off-label uses in this presentation. All relationships have been mitigated through review.

Event Planners/Reviewers Disclosures: The following event planners and/or reviewers are reported as having no financial interest, arrangement or affiliation with any entity producing, marketing, selling, re-selling, or distributing health care goods or services consumed by, or used on, patients, during the past 24 months: Larry Epp, EdD, Todd Peters, MD, Elizabeth Ryznar, MD, MSc, Louis Marino, MD, Devi Bhuyan, PsyD, Faith Dickerson, PhD, Carrie Etheridge, LCSW-C, Tom Flis, LCPC, Lisa Illum, MLIS, MEd, and Jennifer Tornabene.